Small-Molecule Agonists and Antagonists of the Opioid Receptor-Like Receptor (ORL1, NOP): Ligand-Based Analysis of Structural Factors Influencing Intrinsic Activity at NOP Opioid Ligands with Mixed µ/d Opioid Receptor Interactions: An Emerging Approach to Novel AnalgesicsĢ4. The Role of Crystallography in Drug DesignĢ3. Drug Design: Nicotine, Opioids and Related LigandsĢ1. Dual Dopamine/Serotonin Releasers as Potential Medications for Stimulant and Alcohol Addictions Recognition of Psychostimulants, Antidepressants, and Other Inhibitors of Synaptic Neurotransmitter Uptake by the Plasma Membrane Monoamine TransportersĬhristopher K. Hallucinogen Actions on 5-HT Receptors Reveal Distinct Mechanisms of Activation and Signaling by G Protein-Coupled Receptorsġ8. Regulation of Monoamine Transporters: Influence of Psychostimulants and Therapeutic Antidepressants
? Opioids as Potential Treatments for Stimulant Dependence Recent Advances for the Treatment of Cocaine Abuse: Central Nervous System Immunopharmacotherapyġ5. Serotonin Transporters: Implications for Antidepressant Drug Development Development of the Dopamine Transporter Selective RTI-336 as a Pharmacotherapy for Cocaine Abuseį.
Role of Monoamine Transporters in Mediating Psychostimulant EffectsĮvan L. Transporters & Stimulants & Hallucinogensġ1. Neuronal Nicotinic Acetylcholine Receptor Expression and Function on Nonneuronal Cells Targeting the PDZ Domains of Molecular Scaffolds of Transmembrane Ion ChannelsĪndrea Piserchio, Mark Spaller, Dale F. Viewing Chemokines as a Third Major System of Communication in the Brain RNAi-Directed Inhibition of DC-SIGN by Dendritic Cells: Prospects for HIV-1 Therapy Cocaine- and Amphetamine-Regulated Transcript Peptides Play a Role in Drug Abuse and Are Potential Therapeutic Targets
Monoclonal Antibody Form and Function: Manufacturing the Right Antibodies for Treating Drug AbuseĮric Peterson, S. Symbiotic Relationship of Pharmacogenetics and Drugs of Abuseĥ. Computational Methods in Drug Design: Modeling G Protein-Coupled Receptor Monomers, Dimers, and OligomersĤ. DARPP-32 Mediates the Actions of Multiple Drugs of Abuse
0 kommentar(er)
